| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H44O2.C6H15NO3 |
| Molecular Weight | 489.7718 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
![Structure of Docosanoic acid, compd. with 2,2?,2??-nitrilotris[ethanol]](/img/e7fe816d-c944-4d39-93b6-cc93aa6e3f5b.svg?size=400&version=7&stereo=false "Structure of Docosanoic acid, compd. with 2,2?,2??-nitrilotris[ethanol]")
SMILES
OCCN(CCO)CCO.CCCCCCCCCCCCCCCCCCCCCC(O)=O
InChI
InChIKey=GCACVWDCQDRJLA-UHFFFAOYSA-N
InChI=1S/C22H44O2.C6H15NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24;8-4-1-7(2-5-9)3-6-10/h2-21H2,1H3,(H,23,24);8-10H,1-6H2
Behenic acid is a saturated fatty acid that is derived from the oil extracts of plants and used as a component of conditioning agents. Behenic acid is also a part of a novel complex of lipophilic ingredients developed for the treatment of dry skin. The properties of behenic acid were studied in comparison to others fatty acids and it was found that behenic acid does not inhibit the UDP-glucuronosyltransferase (UGT) 1A1 enzyme. The high levels of behenic acid in patients with low-grade glial tumors is an important indicator of the persistence of tissue integrity and tissue resistance. Therefore, behenic acid levels can be a prognostic factor in glial tumors.
Approval Year
PubMed
Patents
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
![Structure of Docosanoic acid, compd. with 2,2?,2??-nitrilotris[ethanol]](/img/f64cfcf6-ba0e-429e-85dc-1b13b31fc6db.svg "Structure of Docosanoic acid, compd. with 2,2?,2??-nitrilotris[ethanol]")